Literature DB >> 915024

Studies on absorption of a newly developed enteric-coated erythromycin base.

P J McDonald, L E Mather, M J Story.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 915024     DOI： 10.1177/009127007701701007

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  10 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Effect of concomitant food intake on absorption kinetics of erythromycin in healthy volunteers.

Authors:  T Hovi; M Heikinheimo
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Evaluation of the intestinal absorption of erythromycin in man: absolute bioavailability and comparison with enteric coated erythromycin.

Authors:  A A Somogyi; F Bochner; D Hetzel; D B Williams
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

4.  Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base.

Authors:  K Josefsson; T Bergan; L Magni
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects.

Authors:  P D Kroboth; A Brown; J A Lyon; F J Kroboth; R P Juhl
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.

Authors:  T Hovi; K Josefsson; O V Renkonen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Influence of food on absorption of erythromycin ethyl succinate.

Authors:  P J Thompson; K R Burgess; G E Marlin
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

8.  Absorption and bioavailability of oral erythromycin.

Authors:  L E Mather; K L Austin; C R Philpot; P J McDonald
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

9.  The influence of food on the bioavailability of new formulations of erythromycin stearate and base.

Authors:  J Rutland; N Berend; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

10.  Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy.

Authors:  Masayuki Nakamori; Katarzyna Taylor; Hideki Mochizuki; Krzysztof Sobczak; Masanori P Takahashi
Journal:  Ann Clin Transl Neurol       Date:  2015-12-10       Impact factor: 4.511
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.